The Coretec Group Inc. (CRTG) 10-Q 12 Nov 13 2013 Q3 Quarterly report Financial data

Document_And_Entity_Informatio

Document And Entity Information	9 Months Ended
	Sep. 30, 2013	Nov. 09, 2013
Document Information [Line Items]	'	'
Document Type	'10-Q	'
Amendment Flag	'false	'
Document Period End Date	30-Sep-13	'
Document Fiscal Year Focus	'2013	'
Document Fiscal Period Focus	'Q3	'
Trading Symbol	'TDCP	'
Entity Common Stock, Shares Outstanding	'	192,108,289
Entity Registrant Name	'3DICON CORP	'
Entity Central Index Key	'0001375195	'
Current Fiscal Year End Date	'--12-31	'
Entity Filer Category	'Smaller Reporting Company	'

BALANCE_SHEETS

BALANCE SHEETS (USD $)	Sep. 30, 2013	Dec. 31, 2012
Current assets:	'	'
Cash	$18,360	$1,350
Prepaid expenses	25,922	12,610
Accounts receivable	0	78,428
Total current assets	44,282	92,388
Net property and equipment	0	4,280
Deferred debt costs	7,500	0
Deposits-other	2,315	2,315
Total Assets	54,097	98,983
Current liabilities:	'	'
Current maturities of convertible notes and debentures payable	516,980	660,840
Warrant exercise advances	181,451	1
Accounts payable	178,248	324,473
Accrued salaries	8,240	10,958
Accrued interest on debentures	16,075	12,246
Total current liabilities	900,994	1,008,518
Convertible debentures payable	70,225	73,665
Long term debt	70,225	73,665
Total Liabilities	971,219	1,082,183
Common stock subject to put rights and call right, 1,685,714 shares	485,649	485,649
Stockholders' deficiency:	'	'
Common stock $.0002 par, 1,500,000,000 shares authorized; 141,128,835 and 45,934,839 shares issued and outstanding at September 30, 2013 and December 31, 2012, respectively	28,226	9,187
Additional paid-in capital	18,242,707	17,044,786
Deficit accumulated during development stage	-19,673,704	-18,522,822
Total Stockholders' Deficiency	-1,402,771	-1,468,849
Total Liabilities and Stockholders' Deficiency	$54,097	$98,983

BALANCE_SHEETS_Parenthetical

BALANCE SHEETS (Parenthetical) (USD $)	Sep. 30, 2013	Dec. 31, 2012
Common stock subject to put rights and call right, shares	1,685,714	1,685,714
Common stock, par	$0.00	$0.00
Common stock, shares authorized	1,500,000,000	1,500,000,000
Common stock, shares issued	141,128,835	45,934,839
Common stock, shares outstanding	141,128,835	45,934,839

STATEMENTS_OF_OPERATIONS

STATEMENTS OF OPERATIONS (USD $)	3 Months Ended		9 Months Ended		153 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013
Income:	'	'	'	'	'
License fee	$0	$0	$0	$0	$25,000
Sales	0	0	1,500	0	42,297
Grant income	0	0	0	63,669	281,492
Total income	0	0	1,500	63,669	348,789
Expenses:	'	'	'	'	'
Research and development	90,035	127,759	280,796	414,149	4,958,471
General and administrative	227,111	502,468	811,964	1,120,660	14,406,261
Interest	6,239	35,887	59,622	40,597	657,761
Total expenses	323,385	666,114	1,152,382	1,575,406	20,022,493
Net loss	($323,385)	($666,114)	($1,150,882)	($1,511,737)	($19,673,704)
Loss per share:	'	'	'	'	'
Basic and diluted	($0.00)	($0.02)	($0.02)	($0.04)	'
Weighted average shares outstanding, Basic and diluted	103,714,220	41,459,140	73,495,248	37,991,154	'

STATEMENTS_OF_CHANGES_IN_STOCK

STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIENCY (USD $)

3 Months Ended

9 Months Ended

12 Months Ended

153 Months Ended

Sep. 30, 2013

Sep. 30, 2013

Sep. 30, 2012

Dec. 31, 2012

Dec. 31, 2011

Dec. 31, 2010

Dec. 31, 2009

Dec. 31, 2008

Dec. 31, 2007

Dec. 31, 2006

Dec. 31, 2005

Dec. 31, 2004

Dec. 31, 2003

Dec. 31, 2002

Dec. 31, 2001

Sep. 30, 2013

Beginning Balance

'

($1,468,849)

($1,246,529)

($1,246,529)

($1,626,230)

($1,792,157)

($2,211,746)

($921,198)

($881,748)

($386,897)

($369,457)

$20,929

$112,433

$162,972

$221,212

$221,212

Accrue compensation earned but unrecorded

'

'

'

'

'

'

'

'

'

'

'

'

-90,000

-60,000

-60,000

'

Warrants and options exercised

'

374,960

'

871,052

756,840

'

'

'

'

'

'

'

'

'

'

'

Debentures converted

'

490,150

'

39,779

703,546

279,191

483,004

965,309

1,677,183

150,000

'

'

'

'

'

'

Escrowed shares cancelled

'

'

'

'

0

'

'

'

'

'

'

'

'

'

'

'

Stock based compensation

'

'

'

354,040

285,600

418,112

'

654,199

1,274,666

'

'

'

'

'

'

'

Options exercised and escrowed shares

'

'

'

'

'

'

'

0

0

'

'

'

'

'

'

'

Warrants issued to purchase common stock

'

'

'

'

'

'

'

'

87,864

33,800

'

'

'

'

'

'

Retrospective adjustment for reverse common stock split

'

'

'

'

'

'

'

'

'

'

'

'

0

'

'

'

Warrants converted to purchase common stock

'

'

'

'

'

'

'

'

463,920

568,500

'

'

'

'

'

'

Par value $0.0001 to $0.0002

'

'

'

'

'

'

'

'

'

'

'

'

0

'

'

'

Stock warrants exercised

'

'

'

'

'

518,000

382,590

362,694

'

'

174,000

61,000

'

'

'

'

Options issued for cash

'

100,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Net loss for the period

-323,385

-1,150,882

-1,511,737

-2,101,702

-2,320,469

-1,523,737

-1,566,835

-3,611,550

-3,928,996

-1,469,888

-592,811

-617,875

-51,851

-267,887

-259,221

-19,673,704

Ending Balance

-1,402,771

-1,402,771

'

-1,468,849

-1,246,529

-1,626,230

-1,792,157

-2,211,746

-921,198

-881,748

-386,897

-369,457

20,929

112,433

162,972

-1,402,771

Stock issued for services

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Stock issued

'

220,350

'

246,100

355,205

232,886

538,354

313,800

155,426

206,537

26,371

76,489

15,347

129,448

188,131

'

Stock issued for cash

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Stock issued

'

'

'

'

'

10,000

202,000

25,000

192,136

16,200

72,300

28,808

35,000

147,900

72,850

'

Warrants issued to purchase common stock at $.025

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Warrants issued to purchase common stock

'

'

'

'

'

'

'

'

'

'

62,300

18,900

'

'

'

'

Warrants issued to purchase common stock at $.05

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Warrants issued to purchase common stock

'

'

'

'

'

'

'

'

'

'

140,400

42,292

'

'

'

'

Additional founders shares issued

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Stock issued

'

'

'

'

'

'

'

'

'

'

'

0

'

'

'

'

Stock issued to settle liabilities

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Stock issued

'

31,500

'

366,364

556,027

214,414

'

'

'

'

100,000

'

'

'

'

'

Stock issued for interest

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Stock issued

'

'

'

2,047

42,952

17,061

43,309

'

38,351

'

'

'

'

'

'

'

Accounts payable

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Stock issued

'

'

'

'

'

'

323,662

'

'

'

'

'

'

'

'

'

Warrants issued to purchase common stock

'

'

'

'

'

'

13,505

'

'

'

'

'

'

'

'

'

Common Stock

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Beginning Balance (in shares)

'

45,934,839

32,928,654

32,928,654

757,539,307

343,690,812

157,515,766

127,125,232

98,336,656

73,947,656

56,737,656

5,241,656

35,689,560

31,133,560

27,723,750

27,723,750

Beginning Balance

'

9,187

6,586

6,586

151,508

68,738

31,503

25,425

19,666

14,789

11,347

1,048

35,690

31,134

27,724

27,724

Accrue compensation earned but unrecorded

'

'

'

'

'

'

'

'

'

'

'

'

0

0

0

'

Warrants and options exercised (in shares)

'

983

'

2,285

12,308,915

'

'

'

'

'

'

'

'

'

'

'

Warrants and options exercised

'

1

'

1

2,462

'

'

'

'

'

'

'

'

'

'

'

Debentures converted (in shares)

'

81,588,787

'

9,884,674

252,267,600

255,650,977

77,451,141

15,257,163

17,215,200

3,000,000

'

'

'

'

'

'

Debentures converted

'

16,318

'

1,976

50,453

51,130

15,490

3,052

3,442

600

'

'

'

'

'

'

Escrowed shares cancelled (In Shares)

'

'

'

'

-4,310,446

'

'

'

'

'

'

'

'

'

'

'

Escrowed shares cancelled

'

'

'

'

-862

'

'

'

'

'

'

'

'

'

'

'

Stock based compensation

'

'

'

0

0

0

'

0

0

'

'

'

'

'

'

'

Options exercised and escrowed shares (in shares)

'

'

'

'

'

'

'

8,671,460

222,707

'

'

'

'

'

'

'

Options exercised and escrowed shares

'

'

'

'

'

'

'

1,734

45

'

'

'

'

'

'

'

Warrants issued to purchase common stock

'

'

'

'

'

'

'

'

0

0

'

'

'

'

'

'

Retrospective adjustment for reverse common stock split (in Shares)

'

'

'

'

-1,119,574,221

'

'

'

'

'

'

'

-47,174,904

'

'

'

Retrospective adjustment for reverse common stock split

'

'

'

'

-223,915

'

'

'

'

'

'

'

0

'

'

'

Warrants converted to purchase common stock (in shares)

'

'

'

'

'

'

'

'

8,585,956

16,489,000

'

'

'

'

'

'

Warrants converted to purchase common stock

'

'

'

'

'

'

'

'

1,717

3,297

'

'

'

'

'

'

Par value $0.0001 to $0.0002

'

'

'

'

'

'

'

'

'

'

'

'

-51,369

'

'

'

Stock warrants exercised (in shares)

'

'

'

'

'

47,523

35,100

1,347,261

'

'

5,260,000

2,100,000

'

'

'

'

Stock warrants exercised

'

'

'

'

'

9

7

269

'

'

1,052

420

'

'

'

'

Options issued for cash

'

0

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Net loss for the period

'

0

'

0

0

0

0

0

0

0

0

0

0

0

0

'

Ending Balance (in shares)

141,128,835

141,128,835

'

45,934,839

32,928,654

757,539,307

343,690,812

157,515,766

127,125,232

98,336,656

73,947,656

56,737,656

5,241,656

35,689,560

31,133,560

141,128,835

Ending Balance

28,226

28,226

'

9,187

6,586

151,508

68,738

31,503

25,425

19,666

14,789

11,347

1,048

35,690

31,134

28,226

Common Stock | Stock issued for services

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Stock issued (in shares)

'

12,505,475

'

2,248,640

30,072,595

97,684,416

68,506,130

4,598,973

817,727

4,700,000

5,850,000

24,036,000

15,347,000

3,077,000

2,681,310

'

Stock issued

'

2,501

'

450

6,015

19,538

13,701

920

164

940

1,170

4,807

15,347

3,077

2,681

'

Common Stock | Stock issued for cash

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Stock issued (in shares)

'

'

'

'

'

5,714,286

20,607,841

515,677

1,188,960

200,000

1,100,000

360,000

1,380,000

1,479,000

728,500

'

Stock issued

'

'

'

'

'

1,143

4,122

103

238

40

220

72

1,380

1,479

729

'

Common Stock | Warrants issued to purchase common stock at $.025

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Warrants issued to purchase common stock

'

'

'

'

'

'

'

'

'

'

0

0

'

'

'

'

Common Stock | Warrants issued to purchase common stock at $.05

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Warrants issued to purchase common stock

'

'

'

'

'

'

'

'

'

'

0

0

'

'

'

'

Common Stock | Additional founders shares issued

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Stock issued (in shares)

'

'

'

'

'

'

'

'

'

'

'

25,000,000

'

'

'

'

Stock issued

'

'

'

'

'

'

'

'

'

'

'

5,000

'

'

'

'

Common Stock | Stock issued to settle liabilities

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Stock issued (in shares)

'

1,098,751

'

869,510

97,530,393

48,657,897

'

'

'

'

5,000,000

'

'

'

'

'

Stock issued

'

219

'

173

19,506

9,732

'

'

'

'

1,000

'

'

'

'

'

Common Stock | Stock issued for interest

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Stock issued (in shares)

'

'

'

1,076

7,094,511

6,093,396

8,310,128

'

767,026

'

'

'

'

'

'

'

Stock issued

'

'

'

1

1,419

1,218

1,662

'

153

'

'

'

'

'

'

'

Common Stock | Accounts payable

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Stock issued (in shares)

'

'

'

'

'

'

11,264,706

'

'

'

'

'

'

'

'

'

Stock issued

'

'

'

'

'

'

2,253

'

'

'

'

'

'

'

'

'

Warrants issued to purchase common stock

'

'

'

'

'

'

0

'

'

'

'

'

'

'

'

'

Additional Paid-In Capital

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Beginning Balance

'

17,044,786

15,168,005

15,168,005

12,322,913

10,716,019

8,766,830

6,451,906

2,568,119

1,597,959

1,026,030

808,840

723,851

451,059

193,488

193,488

Accrue compensation earned but unrecorded

'

'

'

'

'

'

'

'

'

'

'

'

0

0

0

'

Warrants and options exercised

'

374,959

'

871,051

754,378

'

'

'

'

'

'

'

'

'

'

'

Debentures converted

'

473,832

'

37,803

653,093

228,061

467,514

962,257

1,673,741

149,400

'

'

'

'

'

'

Escrowed shares cancelled

'

'

'

'

862

'

'

'

'

'

'

'

'

'

'

'

Stock based compensation

'

'

'

354,040

285,600

418,112

'

654,199

1,274,666

'

'

'

'

'

'

'

Options exercised and escrowed shares

'

'

'

'

'

'

'

-1,734

-45

'

'

'

'

'

'

'

Warrants issued to purchase common stock

'

'

'

'

'

'

'

'

87,864

33,800

'

'

'

'

'

'

Retrospective adjustment for reverse common stock split

'

'

'

'

223,915

'

'

'

'

'

'

'

0

'

'

'

Warrants converted to purchase common stock

'

'

'

'

'

'

'

'

462,203

565,203

'

'

'

'

'

'

Par value $0.0001 to $0.0002

'

'

'

'

'

'

'

'

'

'

'

'

51,369

'

'

'

Stock warrants exercised

'

'

'

'

'

517,991

382,583

362,425

'

'

172,948

60,580

'

'

'

'

Options issued for cash

'

100,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Net loss for the period

'

0

'

0

0

0

0

0

0

0

0

0

0

0

0

'

Ending Balance

18,242,707

18,242,707

'

17,044,786

15,168,005

12,322,913

10,716,019

8,766,830

6,451,906

2,568,119

1,597,959

1,026,030

808,840

723,851

451,059

18,242,707

Additional Paid-In Capital | Stock issued for services

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Stock issued

'

217,849

'

245,650

349,190

213,348

524,653

312,880

155,262

205,597

25,201

71,682

0

126,371

185,450

'

Additional Paid-In Capital | Stock issued for cash

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Stock issued

'

'

'

'

'

8,857

197,878

24,897

191,898

16,160

72,080

28,736

33,620

146,421

72,121

'

Additional Paid-In Capital | Warrants issued to purchase common stock at $.025

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Warrants issued to purchase common stock

'

'

'

'

'

'

'

'

'

'

62,300

18,900

'

'

'

'

Additional Paid-In Capital | Warrants issued to purchase common stock at $.05

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Warrants issued to purchase common stock

'

'

'

'

'

'

'

'

'

'

140,400

42,292

'

'

'

'

Additional Paid-In Capital | Additional founders shares issued

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Stock issued

'

'

'

'

'

'

'

'

'

'

'

-5,000

'

'

'

'

Additional Paid-In Capital | Stock issued to settle liabilities

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Stock issued

'

31,281

'

366,191

536,521

204,682

'

'

'

'

99,000

'

'

'

'

'

Additional Paid-In Capital | Stock issued for interest

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Stock issued

'

'

'

2,046

41,533

15,843

41,647

'

38,198

'

'

'

'

'

'

'

Additional Paid-In Capital | Accounts payable

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Stock issued

'

'

'

'

'

'

321,409

'

'

'

'

'

'

'

'

'

Warrants issued to purchase common stock

'

'

'

'

'

'

13,505

'

'

'

'

'

'

'

'

'

Deficit Accumulated During the Development Stage

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Beginning Balance

'

-18,522,822

-16,421,120

-16,421,120

-14,100,651

-12,576,914

-11,010,079

-7,398,529

-3,469,533

-1,999,645

-1,406,834

-788,959

-647,108

-319,221

0

0

Accrue compensation earned but unrecorded

'

'

'

'

'

'

'

'

'

'

'

'

-90,000

-60,000

-60,000

'

Warrants and options exercised

'

0

'

0

0

'

'

'

'

'

'

'

'

'

'

'

Debentures converted

'

0

'

0

0

0

0

0

0

0

'

'

'

'

'

'

Escrowed shares cancelled

'

'

'

'

0

'

'

'

'

'

'

'

'

'

'

'

Stock based compensation

'

'

'

0

0

0

'

0

0

'

'

'

'

'

'

'

Options exercised and escrowed shares

'

'

'

'

'

'

'

0

0

'

'

'

'

'

'

'

Warrants issued to purchase common stock

'

'

'

'

'

'

'

'

0

0

'

'

'

'

'

'

Retrospective adjustment for reverse common stock split

'

'

'

'

'

'

'

'

'

'

'

'

0

'

'

'

Warrants converted to purchase common stock

'

'

'

'

'

'

'

'

0

0

'

'

'

'

'

'

Par value $0.0001 to $0.0002

'

'

'

'

'

'

'

'

'

'

'

'

0

'

'

'

Stock warrants exercised

'

'

'

'

'

0

0

0

'

'

0

0

'

'

'

'

Options issued for cash

'

0

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Net loss for the period

'

-1,150,882

'

-2,101,702

-2,320,469

-1,523,737

-1,566,835

-3,611,550

-3,928,996

-1,469,888

-592,811

-617,875

-51,851

-267,887

-259,221

'

Ending Balance

-19,673,704

-19,673,704

'

-18,522,822

-16,421,120

-14,100,651

-12,576,914

-11,010,079

-7,398,529

-3,469,533

-1,999,645

-1,406,834

-788,959

-647,108

-319,221

-19,673,704

Deficit Accumulated During the Development Stage | Stock issued for services

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Stock issued

'

0

'

0

0

0

0

0

0

0

0

0

0

0

0

'

Deficit Accumulated During the Development Stage | Stock issued for cash

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Stock issued

'

'

'

'

'

0

0

0

0

0

0

0

0

0

0

'

Deficit Accumulated During the Development Stage | Warrants issued to purchase common stock at $.025

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Warrants issued to purchase common stock

'

'

'

'

'

'

'

'

'

'

0

0

'

'

'

'

Deficit Accumulated During the Development Stage | Warrants issued to purchase common stock at $.05

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Warrants issued to purchase common stock

'

'

'

'

'

'

'

'

'

'

0

0

'

'

'

'

Deficit Accumulated During the Development Stage | Additional founders shares issued

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Stock issued

'

'

'

'

'

'

'

'

'

'

'

0

'

'

'

'

Deficit Accumulated During the Development Stage | Stock issued to settle liabilities

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Stock issued

'

0

'

0

0

0

'

'

'

'

0

'

'

'

'

'

Deficit Accumulated During the Development Stage | Stock issued for interest

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Stock issued

'

'

'

0

0

0

0

'

0

'

'

'

'

'

'

'

Deficit Accumulated During the Development Stage | Accounts payable

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Stock issued

'

'

'

'

'

'

0

'

'

'

'

'

'

'

'

'

Warrants issued to purchase common stock

'

'

'

'

'

'

$0

'

'

'

'

'

'

'

'

'

STATEMENTS_OF_CHANGES_IN_STOCK1

STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIENCY (Parenthetical) (USD $)	12 Months Ended
	Dec. 31, 2003	Dec. 31, 2003	Dec. 31, 2005	Dec. 31, 2004	Dec. 31, 2005	Dec. 31, 2004
	Maximum	Minimum	Warrants issued to purchase common stock at $.025	Warrants issued to purchase common stock at $.025	Warrants issued to purchase common stock at $.05	Warrants issued to purchase common stock at $.05
Purchase common stock	'	'	$0.03	$0.03	$0.05	$0.05
Price change of par value	$0.00	$0.00	'	'	'	'

STATEMENTS_OF_CASH_FLOWS

STATEMENTS OF CASH FLOWS (USD $)	9 Months Ended		153 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013
Cash Flows from Operating Activities	'	'	'
Net loss	($1,150,882)	($1,511,737)	($19,673,704)
Adjustments to reconcile net loss to net cash used in operating activities:	'	'	'
Options issued for services	0	325,780	2,986,618
Stock issued for services	220,350	230,350	2,704,445
Stock issued for interest	0	2,047	143,719
Book value of assets retired	0	0	6,529
Amortization of debt issuance costs	35,219	27,169	284,466
Depreciation	4,280	4,147	37,000
Impairment of assets	0	0	292,202
Change in:	'	'	'
Accounts receivable	13,028	3,971	0
Prepaid expenses and other assets	-13,312	3,930	-276,637
Accounts payable and accrued liabilities	84,017	-131,917	2,592,774
Net cash used in operating activities	-807,300	-1,046,260	-10,902,588
Cash Flows from Investing Activities	'	'	'
Purchase of office furniture and equipment	0	0	-43,529
Net cash used in investing activities	0	0	-43,529
Cash Flows from Financing Activities	'	'	'
Proceeds from stock and warrant sales, exercise of warrants and warrant exercise advances	621,810	688,831	5,999,376
Proceeds from issuance of debentures, notes and options	202,500	375,300	4,965,091
Net cash provided by financing activities	824,310	1,064,131	10,964,467
Net increase in cash	17,010	17,871	18,350
Cash, beginning of period	1,350	17,666	10
Cash, end of period	18,360	35,537	18,360
Non-Cash Investing and Financing Activities	'	'	'
Conversion of debentures to common stock (net)	490,150	38,259	4,787,610
Cash paid for interest	17,832	1,838	321,528
Stock issued to satisfy payables	31,500	366,364	2,385,117
Debenture issued to satisfy payable	197,631	0	352,547
Stock issued subject to put rights and call right to satisfy payables	$0	$0	$485,649

Uncertainties_and_Use_of_Estim

Uncertainties and Use of Estimates	9 Months Ended
	Sep. 30, 2013
Uncertainties and Use Of Estimates [Abstract]	'
Uncertainties and Use of Estimates	'
	Note 1 – Uncertainties and Use of Estimates
	Basis of Presentation
	The accompanying financial statements of 3DIcon Corporation (the “Company”) have been prepared without audit pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). Certain information and footnote disclosures normally included in the financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted pursuant to such rules and regulations. The Company believes that the disclosures made are adequate to make the information presented not misleading. These financial statements should be read in conjunction with the Company's year-end audited financial statements and related footnotes included in the previously filed 10-K. In the opinion of management, all adjustments, consisting only of normal recurring adjustments, necessary to present fairly the financial position of the Company as of September 30, 2013, and the statements of its operations for the three and nine months ended September 30, 2013 and 2012, and the period from inception (January 1, 2001) to September 30, 2013, and cash flows for the nine-month periods ended September 30, 2013 and 2012, and the period from inception (January 1, 2001) to September 30, 2013, have been included. The results of operations for interim periods may not be indicative of the results which may be realized for the full year.
	Use of Estimates
	The preparation of financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues, expenses and the disclosure of contingent assets and liabilities. Actual results could differ from the estimates and assumptions used.
	Revenue Recognition
	Revenues from software license fees are accounted for in accordance with Accounting Standards Codification (“ASC”) 985-605, “Software Revenue Recognition”.  The Company recognizes revenue when (i) persuasive evidence of an arrangement exists; (ii) delivery has occurred or services have been rendered; (iii) the sales price is fixed or determinable; and (iv) collectability is reasonably assured.
	Grant revenue is recognized when earned.
	Recent Accounting Pronouncements
	Based on management's assessment no new accounting standards, if adopted, would have a material impact on the accompanying financial statements.
	Uncertainties
	The accompanying financial statements have been prepared on a going concern basis.  The Company is in the development stage and has insufficient revenue and capital commitments to fund the development of its planned product and to pay operating expenses.
	The Company has realized a cumulative net loss of $19,673,704 for the period from inception (January 1, 2001) to September 30, 2013, and a net loss of $1,150,882 and $1,511,737 for the nine-months ended September 30, 2013 and 2012, respectively.
	The ability of the Company to continue as a going concern during the next year depends on the successful completion of the Company's capital raising efforts to fund the development of its planned products.  The financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.
	Management plans to fund the future operations of the Company with existing cash, grants and investor funding. Pursuant to the 4.75% Convertible Debenture due in December 2014, beginning in November 2007, Golden State is obligated to submit conversion notices in an amount such that Golden State receives 1% of the outstanding shares of the Company every calendar quarter for a period of one year or until the Debenture is converted in full.  In connection with each conversion, Golden State is expected to simultaneously exercise a percentage of warrants equal to the percentage of the principal being converted.  The warrants are exercisable at $381.50 per share.  The number of warrants exercisable is subject to certain beneficial ownership limitations contained in the 4.75% Convertible Debenture (“the Beneficial Ownership Limitations”).  The Beneficial Ownership Limitations prevent Golden State from converting on the 4.75% Convertible Debenture or exercising warrants if such conversion or exercise would cause Golden State’s holdings to exceed 9.99% of the Company’s issued and outstanding common stock.  Subject to the Beneficial Ownership Limitations and provided that Golden State is able to sell the shares under Rule 144, Golden State is required to convert $85.71 of the 4.75% Convertible Debenture and exercise 857 warrants per month.  Based upon our current stock price, our issued and outstanding shares as of September 30, 2013 and ignoring the impact of the Beneficial Ownership Limitations, the Company may receive up to $327,000 per month in funding from Golden State as a result of warrant exercises. During the nine-months ended September 30, 2013, the Company received $621,810 in funding under the terms of the 4.75% Convertible Debenture (see Note 4).
	Additionally, the Company is continuing to pursue financing through private offerings of debt or common stock.
	Registration Statement on Form S-1
	Pursuant to a Registration Statement on Form S-1 and the prospectus therein, filed on July 3, 2012, and amendment thereto, the Registration Statement was declared effective on February 13, 2013.

Sponsored_Research_Agreement_S

Sponsored Research Agreement ("SRA") Common Stock Subject to Put Right and Call Right	9 Months Ended
	Sep. 30, 2013
Sponsored Research Agreement Common Stock Subject To Put Rights and Call Right [Abstract]	'
Sponsored Research Agreement ("SRA") Common Stock Subject to Put Right and Call Right	'
	Note 2 – Sponsored Research Agreement ("SRA") Common Stock Subject to Put Right and Call Right
	Since April 20, 2002, the Company has entered into a number of Sponsored Research Agreements with the University of Oklahoma (“OU”) as follows:
	Phase I: “Pilot Study to Investigate Digital Holography”, April 20, 2004. The Company paid OU $14,116.
	Phase II: “Investigation of 3-Dimensional Display Technologies”, April 15, 2005, as amended. The Company paid OU $528,843.
	Phase III: “3-Dimensional Display Development”. The Company made partial payment to OU by issuing 121,848 post-split equivalent shares with a market price of $290,000 on October 14, 2008 and final payment on December 1, 2010 in the amount of $525,481 of which $40,481 was in cash and 1,685,714 post-split equivalent shares of Company stock (the “Shares”). The Shares are subject to an OU ‘put’ right and a 3DIcon ‘call’ right.
	OU “Put” Right on the Shares
	First “put” period: December 1, 2012 to November 30, 2013. If the Shares (held plus previously sold) are valued at less than $100,000 then OU can “put” one-tenth of the Shares for $50,000 plus accrued interest retroactive to December 1, 2012 less the value of sold shares.
	Second “put” period: December 1, 2013 to November 30, 2014. If the Shares (held & previously sold) are valued at less than $970,000 then OU can “put” the remaining Shares for $485,000 plus accrued interest retroactive to December 1, 2012 less the value of shares previously sold or redeemed during the first “put”.
	3DIcon “Call” Right on the Shares
	Commencing December 1, 2012, the Company shall have the right to “call” the Shares for an amount equal to $970,000 less the amount (if any) of prior Shares by OU including amounts “put” to 3DIcon.
	The Company has presented the Shares outside of deficit in the mezzanine section of the balance sheets, as the Agreement includes a put right, which is not solely within the control of the Company.
	The Agreement also amended the existing agreements between the Company and OU such that all intellectual property, including all inventions and or discoveries, patentable or un-patentable, developed before July 28, 2008 by OU under the SRA is owned by OU. All intellectual property, including all inventions and/or discoveries, patentable or un-patentable, developed jointly by the Company and OU at any time is jointly owned by the Company and OU. Finally, all intellectual property developed by the Company after July 28, 2008, including all inventions and or discoveries, patentable or un-patentable, is owned by the Company.

OCAST_Grant

OCAST Grant	9 Months Ended
	Sep. 30, 2013
Oklahoma Center For Advancement Of Science and Technology Grant [Abstract]	'
OCAST Grant	'
	Note 3 – OCAST Grant
	The Oklahoma Center for the Advancement of Science and Technology approved the Company’s application for funding of a matching grant titled 800 Million Voxels Volumetric Display, on November 19, 2008.  The two-year matching grant, totaling $299,984, had a start date of January 1, 2009.  The Company received approval for a no cost extension request for the first year of the contract. With the new modification, the first year ended on August 31, 2010.  The award was for a maximum of $149,940 for 2009 and the remainder for 2011.  The Company received approval for a no cost extension request for the second year of the contract and, with the new modification, the second year ended on August 31, 2012. The Company earned $-0- and $63,669 from the grant during the nine-month periods ended September 30, 2013 and 2012, respectively and $281,492 from inception to date.
	During the nine-month periods ended September 30, 2013 and 2012, the Company charged operations $-0- and $12,071, respectively, pursuant to the direct costs incurred and for the use of the OU lab facilities in regard to the OCAST grant.
	On July 2, 2013, the Company issued a press release announcing that the Company was awarded a $300,000 grant in this year’s Oklahoma Applied Research Support competition sponsored by the Oklahoma Center for the Advancement of Science and Technology. The Company explained that the grant money will be used to support the development of the Company’s first Product Platform, which will be the basis for a family of products based on the Company’s CSpace® volumetric 3D display technology.

Debentures_and_Notes_Payable

Debentures and Notes Payable	9 Months Ended
	Sep. 30, 2013
Debentures and Notes Payable [Abstract]	'
Debentures and Notes Payable	'
	Note 4 – Debentures and Notes Payable
	Debentures payable consist of the following:
		September 30,		December 31,
		2013		2012
	Senior Convertible Debentures:
	10% Convertible debentures to Directors due June 2014	$	30,000	$	-
	10% Convertible debenture due November 2013		29,007		29,007
	4.75% Convertible debenture due December 2014		70,225		73,665
	5.0% Convertible notes due 2013 (net of $12,792 and $6,167 OID)		109,228		168,833
	15% Convertible bridge notes due 2014		158,987		403,000
	Settlement Agreement 3(a)(10)		129,758		-
	15% Convertible bridge note to Director due December 2013		60,000		60,000
	Total Debentures		587,205		734,505
	Less - Current Maturities		-516,980		-660,840
	Long-term Debentures	$	70,225	$	73,665
	Director Debenture
	On June 24, 2013, the Company issued to Victor Keen and Martin Keating, Directors of the Company, (“Directors”) 10% convertible debentures in a principal amount of $15,000 each, due June 26, 2014. The Directors may elect to convert all or any portion of the outstanding principal amount of the debentures at an exercise price of $0.01 per share. Provided that the debentures are paid in full or on before the maturity date, no interest shall accrue on the unpaid balance of the principal amount. In the event that the debentures are not paid in full on or before the maturity date, interest shall accrue on the unpaid outstanding balance of the principal amount of the debentures from June 26, 2013, until paid, at the fixed rate of ten percent (10%) per annum.
	Newton, O'Connor, Turner & Ketchum 10% Convertible Debenture
	On December 20, 2012, the Company issued to Newton, O'Connor, Turner & Ketchum (“NOTK”) a 10% convertible debenture in a principal amount of $29,007, initially due September 30, 2013 and extended to November 30, 2013.  NOTK may elect to convert all or any portion of the outstanding principal amount of the debenture at an exercise price of $0.02534 per share. The Company was indebted to NOTK for legal services performed for the Company and reimbursement of expenses in rendition of those services for the period ended December 31, 2012. The debenture was issued in settlement of the indebtedness.
	4.75% Convertible Debenture due December 31, 2014
	On November 3, 2006, the Company issued to Golden State a 4.75% convertible debenture in a principal amount of $100,000, due 2014, and warrants to buy 28,571 post-split equivalent shares of the common stock at an exercise price of $381.50 per post-split share.  In connection with each conversion, Golden State is expected to simultaneously exercise a percentage of warrants equal to the percentage of the principal being converted.  During the year ended December 31, 2012, Golden State converted $7,991 of the $100,000 debenture into 9,577,906 post-split shares of common stock, exercised warrants to purchase 2,285 post-split shares of common stock at $381.50 per share based on the formula in the convertible debenture. Additionally Golden Gate advanced $789,111 against future exercises of warrants of which $805,652 was applied to the exercise of warrants leaving $1.00 of unapplied advances at December 31, 2012. During 2013, Golden State converted $3,440 of the $100,000 debenture into 18,466,089 post-split shares of common stock, exercised warrants to purchase 983 post-split shares of common stock at $381.50 per share based on the formula in the convertible debenture. Additionally Golden State advanced $621,810 against future exercises of warrants of which $374,960 was applied to the exercise of warrants leaving $181,451 of unapplied advances at September 30, 2013.
	The conversion price for the 4.75% $100,000 convertible debenture is the lesser of (i) $4.00 (pre-split) or (ii) 80% of the average of the five lowest volume weighted average prices during the twenty (20) trading days prior to the conversion. If Golden State elects to convert a portion of the debenture and, on the day that the election is made, the volume weighted average pre-split price is below $0.02, the Company shall have the right to prepay that portion of the debenture that Golden State elected to convert, plus any accrued and unpaid interest, at 135% of such amount.
	5% Convertible Promissory Note #1
	On June 6, 2012, the Company issued and sold a convertible promissory note ("Note #1") in the principal amount of $275,000 to JMJ Financial (“JMJ”). Note #1 includes a $25,000 original issue discount (the “OID”) that will be prorated based on the advances actually paid to the Company.  JMJ advanced $75,000 and earned $6,000 OID during 2012. During 2013, JMJ advanced an additional $80,000 on the note and earned $22,645 OID. Additionally, JMJ converted $86,625 of the note into 6,057,305 shares of common stock at an average of $0.0143 per share based on the formula in the note. In addition to the OID, Note #1 provides for a one-time interest charge of 5% to be applied to the principal sum advanced. Pursuant to the terms of Note #1, JMJ may, at its election, convert all or a part of Note #1 into shares of the Company's common stock at a conversion rate equal to the lesser of (i) $0.35 or (ii) 70% of the lowest trade price during the twenty-five trading days prior to JMJ’s election to convert. If the Company repays Note #1 on or before ninety days from the date it was issued, the interest rate will be zero percent. If the Company does not repay Note #1 on or before ninety days from the date it was issued, a one-time interest charge of 5% shall be applied to the principal sum. The Company did not repay Note #1 within the ninety-day period and $2,500 of interest has been accrued. The principal of Note #1 is due one year from the date of each of the principal amounts advanced.
	5% Convertible Promissory Note #2
	On August 1, 2012, the Company issued and sold a convertible promissory note #2 (“Note #2") in the principal amount of $140,000 to JMJ. Note #2 includes a $15,000 OID that will be prorated based on the advances actually paid to the Company. During 2012, JMJ advanced $75,000 on Note #2 and earned $8,000 OID. During 2013, JMJ converted $88,200 of the note into 6,747,619 shares of common stock at an average of $0.0037 per share based on the formula in the note. In addition to the OID, Note #2 provides for a one-time interest charge of 5% to be applied to the principal sum advanced. Pursuant to the terms of Note #2, JMJ may, at its election, convert all or a part of Note #2 into shares of the Company's common stock at a conversion rate equal to the lesser of (i) $0.15 or (ii) 70% of the lowest trade price during the twenty-five trading days prior to JMJ’s election to convert. If the Company repays Note #2 on or before ninety days from the date it was issued, the interest rate will be zero percent. If the Company does not repay Note #2 on or before ninety days from the date it was issued, a one-time interest charge of 5% shall be applied to the principal. The Company did not repay Note #2 within the ninety day period and $5,000 of interest has been accrued. The principal of Note #2 is due one year from the date of each of the principal amounts advanced.
	Note #1 and Note #2 were subject to a Mandatory Registration Agreement (the “Registration Agreement”) whereby no later than August 31, 2012, the Company agreed to file, at its own expense, an amendment (the “Amendment”) to the S-1 Registration Statement (the “Registration Statement”) the Company filed with the SEC on July 3, 2012, to include in such Amendment 4,750,000 shares of common stock issuable under Note #1 and the Note #2. The Company agreed, thereafter, to use its best efforts to cause such Registration Statement to become effective as soon as possible after such filing but in no event later than one hundred and twenty (120) days from the date of the Registration Agreement. Since the Company failed to get the Registration Statement declared effective within the 120 days of the date of the Registration Agreement, a penalty/liquidated damages of $25,000 was added to the balance of Note #2.
	15% Convertible Bridge Notes
	On August 24, 2012, August 28, 2012 and September 11, 2012, the Company issued and sold to three accredited investors Convertible Bridge Notes (the “Bridge Notes”) in the aggregate principal amount of $438,000. The note sold on August 24, 2012, in principal amount of $300,000, was purchased by GCA Strategic Investment Fund Limited, a Bermuda corporation ("GCASIF"). The note sold August 28, 2012, in principal amount of $78,000, was purchased by George Widener. The note sold on September 11, 2012, in principal amount of $60,000, was purchased by Victor Keen, a director of the Company.  The sale of the Bridge Notes in aggregate principal of $438,000 included a $73,000 original issue discount. Accordingly, the Company received $365,000 gross proceeds from which the Company paid legal fees of $25,000 and placement agent fees of $27,675. The Bridge Notes mature in 90 days from their date of issuance and, other than the original issue discount, the Bridge Notes do not carry interest. However, in the event the Bridge Notes are not paid on maturity, all past due amounts will accrue interest at 15% per annum. Upon maturity of the Bridge Notes, the holders of the Bridge Notes may elect to convert all or any portion of the outstanding principal amount of the Bridge Notes into (i) securities sold pursuant to an effective registration statement at the applicable offering price; or (ii) shares of common stock at a conversion price equal to the lesser of 100% of the Volume Weighted Average Price (VWAP), as reported for the 5 trading days prior to (a) the date of issuance of the Bridge Notes, (b) the maturity date of the Bridge Notes, or (c) the first closing date of the securities sold pursuant an effective registration statement. The GCA Bridge Note matured on or about November 22, 2012, on which date all past due amounts of the GCA Bridge Note began accruing interest at 15% per annum. Furthermore, on November 22, 2012, because the shares of the Company’s common stock into which the GCA Bridge Note is convertible were not registered under an effective registration statement (the “Registration Statement”), GCASIF was entitled to liquidated damages equal to 2% of the outstanding principal for each 30 day period after the November 22, 2012 the Registration Statement is not declared effective (the “Liquidated Damages”).
	On December 21, 2012, the Company entered into an amendment agreement (the “GCASIF Amendment”) with GCASIF, the holder of that certain Convertible Bridge Note (the “GCA Bridge Note”) in the principal amount of $300,000.  Pursuant to the GCASIF Amendment, GCASIF agreed to extend the maturity of the GCA Bridge Note from November 22, 2012 to March 21, 2013 and the Company agreed to (i) increase the principal amount of the GCA Bridge Note from $300,000 to $325,000; (ii) amend the conversion price of the GCA Bridge Note to the lesser of $0.04, or 100% of the Volume Weighted Average Price, as reported by Bloomberg, L.P., for the 5 trading days prior to the effective date of the Registration Statement; and (iii) grant additional registration rights to GCASIF from 5,172,414 shares to 8,000,000 shares of the Company’s common stock into which the GCA Bridge Note may be convertible. Furthermore, GCASIF agreed to waive any and all defaults, default interest and the Liquidated Damages due to GCASIF. In connection with the GCASIF Amendment, the Company agreed to pay GCASIF a fee of $20,000. GCASIF agreed to waive any defaults resulting from the non-payment of the GCA Bridge Note, so long as, GCASIF is paid in full by April 15, 2013 or GCASIF elects to convert the GCA Bridge Note into shares of the Company’s common stock on or before April 15, 2013. In April 2013, the GCA Bridge Note was assigned to a successor in interest and the Company executed an amendment to the GCA Bridge Note in order to extend the maturity until July 22, 2014 and reduce the conversion price to the greater of (x) the par value of the Common Stock, or (y) 60% of the lowest closing bid price, as reported by Bloomberg, L.P., for the 10 trading days prior to the date the conversion of all or part of its principal and interest are requested.
	On January 26, 2013, the Company entered into an amendment agreement (the “Widener Amendment”) with George Widener, the holder of that certain Convertible Bridge Note (the “Widener Bridge Note”) in the principal amount of $78,000 issued by the Company on August 30, 2012.
	The Widener Bridge Note matured on or about November 26, 2012, on which date all past due amounts of the Widener Bridge Note began accruing interest at 15% per annum. Pursuant to the Widener Amendment, Mr. Widener agreed to extend the maturity date of the Widener Bridge Note from November 26, 2012 to April 30, 2013 and to waive any and all defaults, default interest and Liquidated Damages then due to Mr. Widener. On April 30, 2013, Mr. Widener converted the entire $78,000 balance of the Widener Bridge Note into 2,025,974 shares of common stock.
	On January 26, 2013, the Company entered into an amendment agreement (the “Keen Amendment”) with Victor F. Keen, the holder of that certain Convertible Bridge Note (the “Keen Bridge Note”) in the principal amount of $60,000 issued by the Company on September 10, 2012.
	The Keen Bridge Note matured on or about December 10, 2012, on which date all past due amounts of the Keen Bridge Note began accruing interest at 15% per annum. Pursuant to the Keen Amendment, Mr. Keen agreed to extend the maturity date of the Keen Bridge Note from December 10, 2012 to April 30, 2013 and to waive any and all defaults, default interest and Liquidated Damages then due to Mr. Keen.
	On July 30, 2013 (the “Amendment Date”), the Company entered into a second amendment agreement (the “Second Keen Amendment”) with Victor Keen, a Director on the Board of Directors of the Company, to amend the Keen Bridge note.
	Pursuant to the Second Keen Amendment, Mr. Keen agreed to extend the maturity of the Note from May 15, 2013 to August 31, 2013 (the “New Maturity Date”) and to waive, if any, existing or prior defaults under the Keen Bridge Note or the Keen SPA and the Company agreed to (i) amend the conversion provision to allow for conversions based on a conversion price calculated on the Amendment Date or the New Maturity Date; and (ii) to include an interest rate equal to 10% per annum, payable on the New Maturity Date, as amended, which accrual shall commence on December 10, 2012.
	On September 30, 2013 (the “Amendment Date”), the Company entered into a third amendment agreement (the “Third Keen Amendment”) with Victor Keen, a Director on the Board of Directors of the Company, to amend the Keen Bridge note.
	Pursuant to the Third Keen Amendment, Mr. Keen agreed to extend the maturity of the Note from August 31, 2013 to December 31, 2013 (the “New Maturity Date”) and to waive, if any, existing or prior defaults under the Keen Bridge Note or the Keen SPA.
	Settlement Agreement
	On July 26, 2013, the Circuit Court in the 12th Judicial Circuit in and for Sarasota County, Florida (the “Court”), entered an Order Granting Approval of Settlement Agreement (the “Order”) approving, among other things, the fairness of the terms and conditions of an exchange pursuant to Section 3(a)(10) of the Securities Act of 1933, as amended, in accordance with a Settlement Agreement (the “Settlement Agreement”) between the Company and IBC Funds, LLC, a Nevada limited liability company (“IBC”), in the matter entitled IBC Funds, LLC v. 3DIcon Corporation, Case No. 2013 CA 5705 NC (the “Action”). IBC commenced the Action against the Company on July 19, 2013 to recover an aggregate of $197,631 of past-due accounts payable of the Company, which IBC had purchased from certain vendors of the Company pursuant to the terms of separate claim purchase agreements between IBC and each of such vendors (the “Assigned Accounts”), plus fees and costs (the “Claim”). The Assigned Accounts relate to certain research, technical, development, accounting and legal services.  The Order provides for the full and final settlement of the Claim and the Action. The Settlement Agreement became effective and binding upon the Company and IBC upon execution of the Order by the Court on July 26, 2013.
	Pursuant to the terms of the Settlement Agreement approved by the Order, on July 26, 2013, the Company issued 650,000 shares of Common Stock as a settlement fee and agreed to issue, in one or more tranches as necessary, that number of shares equal to $197,631 upon conversion to Common Stock at a conversion rate equal to 65% of the lowest closing bid price of the Common Stock during the ten trading days prior to the date the conversion is requested by IBC minus $0.002.  During 2013, IBC converted $67,873 of the note into 16,000,000 shares of common stock at an average of $0.0042 per share based on the formula in the note.

Common_Stock_and_PaidIn_Capita

Common Stock and Paid-In Capital	9 Months Ended
	Sep. 30, 2013
Common Stock, Including Additional Paid In Capital, Net Of Discount [Abstract]	'
Common Stock and Paid-In Capital	'
	Note 5 – Common Stock and Paid-In Capital
	Reverse Stock Split
	The Board of Directors, subject to the approval of the shareholders of the Company, authorized an amendment to the Company's Certificate of Incorporation in order to effect a reverse split of the Company's common stock in a ratio in the range between 1 for 15 and 1 for 35, as will be selected by the Company's Board of Directors (the "Reverse Split").  On October 15, 2011, the Company held an annual meeting of stockholders, at which annual meeting the stockholders approved the Reverse Split and approved the filing of an Amended Certificate of Incorporation to effect the Reverse Split at the discretion of the Board of Directors. On April 27, 2012 the Company filed an Amended Certificate of Incorporation to effect a 1-for-35 reverse split of the Company’s common stock. The reverse stock split was announced by Financial Industry Regulatory Authority on April 26, 2012 and became effective on April 27, 2012. On April 27, 2012, the effective date, every 35 shares of the Company’s issued and outstanding common stocks were combined into one share of common stock. The Company did not issue any fractional shares in connection with the reverse stock split. Stockholders of record who otherwise would have been entitled to receive fractional shares were entitled to, upon surrender to the Company’s transfer agent of certificates representing such shares, cash in lieu thereof.
	Warrants issued
	As of September 30, 2013, there are warrants outstanding to purchase 125,098 shares of common stock at a price of $3.15 per share that expire on May 22, 2014 and, warrants to purchase 96,024 shares of common stock at a price of $3.15 per share that expire on June 1, 2015. Additionally, Golden State has warrants outstanding to purchase 20,062 shares of common stock at a price of $381.50 per share which expire December 31, 2014.
	Common stock and options issued for services and liabilities
	During the nine-month periods ended September 30, 2013 and 2012, shares of common stock totaling 12,505,475 and 1,848,691, respectively were issued for consulting services for which the Company recognized $220,350 and $230,350 of expense, respectively.  Additionally, during the period ending September 30, 2013 and 2012, shares totaling 1,098,751 and 869,510, respectively were issued to consultants for previous services provided to the Company for which the accounts payable liability was reduced by $31,500 and $366,364, respectively.
	Employment Agreement - On March 19, 2012 the Company announced that Sidney Aroesty would resign as CEO and join the Board of Directors. Effective April 15, 2013, Mr. Aroesty resigned as a member of the Board of Directors.
	Employment Agreement - On March 13, 2012, the Company entered into a one (1) year Agreement for At-Will Employment with Assignment of Inventions (“Employment Agreement”) with Mark Willner, pursuant to which Mr. Willner began serving as the Company’s Chief Executive Officer, effective immediately. Under the terms of the Employment Agreement, Mr. Willner is entitled to an annual base salary of $180,000, and, at the discretion of the Company’s Board of Directors, performance-based bonuses and/or salary increases. Pursuant to the Employment Agreement, the Company granted Mr. Willner five-year stock options to purchase 57,143 shares at a price equal to the average price of the five day period prior to March 19, 2012 which was $0.35 (the “Strike Price”). Furthermore, since Mr. Willner remained employed by the Company at the end of each quarter ending June 30, 2012, September 30, 2012 and December 31, 2012, he received additional stock options to purchase 28,571.5 shares at the Strike Price. In addition, since the Company achieved certain quarterly business objectives, Mr. Willner received, at the end of each such quarterly period, a further grant of stock options to purchase 28,571.5 shares at the Strike Price. The estimated fair value of each of the 57,143 block of options, valued at $18,840, was determined using the Black-Scholes option pricing model and was charged to operations in March 2012, June 2012, September 2012 and December 2012. The expected dividend yield of $-0- is based on the average annual dividend yield as of the grant date. Expected volatility of 163% is based on the historical volatility of the stock since July 25, 2007, the day the Company began trading on the Over-The-Counter Bulletin Board. The risk-free interest rate of 1.87% is based on the U.S. Treasury Constant Maturity rates as of the grant date. The expected life of the option of five years is based on historical exercise behavior and expected future experience. (see Note 10)
	The Employment Agreement may be terminated with or without reason by either the Company or Mr. Willner and at any time, upon sixty (60) days written notice. The terms of the Employment Agreement will remain effective for one (1) year and will automatically renew, subject to the same termination rights. Upon termination, the Company will pay any base pay, bonus and benefits that have been earned and are due as of the date of the termination.
	Employment Agreement - On March 16, 2012, the Company entered into a one (1) year Agreement for At-Will Employment with Assignment of Inventions (“Employment Agreement”) with George Melnik, pursuant to which Dr. Melnik began serving as the Company’s Senior Technical Advisor, effective immediately. Under the terms of the Employment Agreement, Dr. Melnik is entitled to an annual base salary of $144,000, and, at the discretion of the Company’s Board of Directors, performance-based bonuses and/or salary increases. Pursuant to the Employment Agreement, the Company granted Dr. Melnik five-year stock options to purchase 28,571 shares at a price equal to the average price of the five day period prior to March 16, 2012 which was $0.35 (the “Strike Price”). Furthermore, since Dr. Melnik remained employed by the Company at the end of each quarter ending June 30, 2012, September 30, 2012 and December 31, 2012, he received additional stock options to purchase 28,571 shares at the Strike Price. In addition, since the Company achieved certain quarterly business objectives, Dr. Melnik received, at the end of each such quarterly period, a further grant of stock options to purchase 28,571 shares at the Strike Price. The estimated fair value of each of the 28,571 block of options, valued at $9,420, was determined using the Black-Scholes option pricing model and was charged to operations in March 2012, June 2012, September 2012 and December 2012. The expected dividend yield of $-0- is based on the average annual dividend yield as of the grant date. Expected volatility of 163% is based on the historical volatility of the stock since July 25, 2007, the day the Company began trading on the Over-The-Counter Bulletin Board. The risk-free interest rate of 1.87% is based on the U.S. Treasury Constant Maturity rates as of the grant date. The expected life of the option of five years is based on historical exercise behavior and expected future experience.
	The Employment Agreement may be terminated with or without reason by either the Company or Dr. Melnik and at any time, upon sixty (60) days written notice. The terms of the Employment Agreement will remain effective for one (1) year and will automatically renew, subject to the same termination rights. Upon termination, the Company will pay any base pay, bonus and benefits that have been earned and are due as of the date of the termination.
	Employment Agreement - On January 28, 2013, the Board of Directors of the Company appointed Ronald Robinson to serve as the Company’s Chief Financial Officer. Accordingly, the Company decided not to renew its agreement with Christopher T. Dunstan pursuant to which Mr. Dunstan served as the Company’s Interim Chief Financial Officer. The Company’s appointment of Mr. Robinson and decision not to renew its agreement with Mr. Dunstan was not as a result of any disagreement between the Company and Mr. Dunstan.
	On April 11, 2013, the Company completed the sale of two options, each to purchase 10,000,000 shares of the Company’s common stock (the “Option Agreements”) to two accredited investors. One of the accredited investors was Victor Keen, a director on the Board of Directors of the Company. Each of the Option Agreements provide for the option to purchase up to 10,000,000 shares of restricted common stock at a purchase price of $0.01 per share. The holders of the Option Agreements may exercise the option to purchase common stock on a cashless basis for a period of five years. Furthermore, the holders of the Option Agreements were granted “piggyback” registration rights for the inclusion, on a subsequent registration statement, the shares of common stock underlying the Option Agreements. The gross proceeds to the Company for the sale of both Option Agreements were $100,000.
	The following summary reflects warrant and option activity for the nine-month period ended September 30, 2013:
		Attached		Golden State		Options
		Warrants		Warrants
	Outstanding December 31, 2012		221,122		21,045		3,045,989
	Granted/purchased		-		-		20,000,000
	Exercised		-		-983		-
	Cancelled		-		-		-
	Outstanding September 30, 2013		221,122		20,062		23,045,989
	Stock options are valued at the date of award, which does not precede the approval date, and compensation cost is recognized in the period the options are granted. Stock options generally become exercisable on the date of grant and expire based on the terms of each grant.
	The estimated fair value of options for common stock granted was determined using the Black-Scholes option pricing model. The expected dividend yield is based on the average annual dividend yield as of the grant date. Expected volatility is based on the historical volatility of our stock. The risk-free interest rate is based on the U.S. Treasury Constant Maturity rates as of the grant date. The expected life of the option is based on historical exercise behavior and expected future experience.

Incentive_Stock_Plan

Incentive Stock Plan	9 Months Ended
	Sep. 30, 2013
Incentive Stock Plan [Abstract]	'
Incentive Stock Plan	'
	Note 6 – Incentive Stock Plan
	In January 2011, the Company established the 3DIcon Corporation 2011 Equity Incentive Stock Plan (the "2011 EIP"). The total number of shares of stock which may be purchased or granted directly by options, stock awards or restricted stock purchase offers, or purchased indirectly through exercise of options granted under the 2011 EIP shall not exceed one hundred million (100,000,000) post-split shares.  The shares are included in a registration statement filed January 14, 2011. Post-split shares totaling -0- and 940,126 were issued from the 2011 EIP during 2013 and 2012 respectively, for services rendered and to satisfy accounts payable to the Company. There are currently 44,673 shares available for issuance under the 2011 EIP.
	In April 2012, the Company established the 3DIcon Corporation 2012 Equity Incentive Plan (the "2012 EIP"). The total number of shares of stock which may be purchased or granted directly by options, stock awards or restricted stock purchase offers, or purchased indirectly through exercise of options granted under the 2012 EIP shall not exceed five million (5,000,000) post-split shares.  The shares are included in a registration statement filed May 3, 2012. Post-split shares totaling -0- and 1,172,514 were issued from the 2012 EIP during 2013 and 2012 respectively, for services rendered and to satisfy accounts payable to the Company. There are currently 1,072,536 shares available for issuance under the 2012 EIP.
	In June 2013, the Company established the 3DIcon Corporation 2013 Equity Incentive Plan (the "2013 EIP"). The total number of shares of stock which may be purchased or granted directly by options, stock awards or restricted stock purchase offers, or purchased indirectly through exercise of options granted under the 2013 EIP shall not exceed twenty million (20,000,000) post-split shares.  The shares are included in a registration statement filed June 10, 2013. Post-split shares totaling 11,849,225 were issued from the 2013 EIP during 2013 for services rendered. There are currently 8,150,755 shares available for issuance under the 2013 EIP.

Office_Lease

Office Lease	9 Months Ended
	Sep. 30, 2013
Office Lease [Abstract]	'
Office Lease	'
	Note 7 – Office Lease
	The Company signed an Office Lease Agreement (the “Lease Agreement”) on April 24, 2008. The Lease Agreement commenced on June 1, 2008 and expired June 1, 2011. On March 8, 2011 the Lease Agreement was amended (amendment 1) to extend the expiration date to May 31, 2012.  On July 24, 2012 the Lease Agreement was amended (amendment 2) to extend the expiration date to July 31, 2015.   The minimum future lease payments to be paid annually under the three-year non-cancellable amended operating lease for office space are as follows:
	2013	$	6,000
	2014		23,000
	2015		13,000
	Total	$	42,000

Related_Party_Transaction

Related Party Transaction	9 Months Ended
	Sep. 30, 2013
Related Party Transactions [Abstract]	'
Related Party Transaction	'
	Note 8 – Related Party Transaction
	3DIcon has engaged the law firm of Newton, O’Connor, Turner & Ketchum as its outside corporate counsel since 2005. John O’Connor, a director of 3DIcon, is the Chairman of Newton, O’Connor, Turner & Ketchum.   During the periods ended September 30, 2013 and September 30, 2012, the Company incurred legal fees to Newton, O’Connor, Turner & Ketchum in the amount of $18,595 and $17,068, respectively.

Dimension_Technologies_Inc_Non

Dimension Technologies Inc. - Non-Binding Letter of Intent	9 Months Ended
	Sep. 30, 2013
Dimension Technologies Inc Non Binding Letter Of Intent [Abstract]	'
Dimension Technologies Inc. - Non-Binding Letter of Intent	'
	Note 9 – Dimension Technologies Inc. - Non-Binding Letter of Intent
	As previously disclosed in the Company’s Current Report on Form 8-K, filed with the SEC on July 19, 2012, on July 13, 2012, 3DIcon Corporation executed a non-binding letter of intent (the “Letter of Intent”) outlining the principal terms and conditions to acquire Dimension Technologies Inc., a privately held New York corporation (“DTI”). DTI is a developer of glasses-free flat screen 3D display technologies and products that are 2D/3D switchable. Founded in 1986, DTI’s intellectual property portfolio includes 10 patents that have been granted in multiple countries. The Letter of Intent is not binding on either party and there is no assurance that the parties will reach a definitive agreement, and if they do, there is no assurance that the conditions there under will be met to consummate the acquisition. Furthermore, if the acquisition is consummated, there is no assurance that the anticipated effects of the transaction will be realized.
	In a letter to the shareholders of the Company, issued on February 20, 2013, the Company  provided an update on the progress the Company is making in its continued efforts to improve the performance of its CSpace technology and to seek out potential acquisitions that would allow the Company to enter the glasses-free flat screen 3D space. The letter to shareholders explains that the Company and DTI mutually agreed not to renew the non-binding letter of intent after a determination was made that DTI’s technology does not fit the specifics of the Company’s business model. At this time, the Company does not have any definitive agreement in place and no assurances can be made the Company will be able to consummate a transaction that would allow such entry into the glasses-free flat screen 3D space.

Subsequent_Events

Subsequent Events	9 Months Ended
	Sep. 30, 2013
Subsequent Events [Abstract]	'
Subsequent Events	'
	Note 10 – Subsequent Events
	Common stock issued for services and liabilities
	Subsequent to September 30, 2013, shares of common stock totaling 2,485,542 were issued for consulting services for which the Company recognized $30,000 of expense.
	Subsequent to September 30, 2013, shares of common stock totaling 14,460,000were issued for $6,265in connection with the Settlement Agreement and the liabilities contained there under.
	Subsequent to September 30, 2013, shares of common stock totaling 14,400,000 were issued to JMJ upon conversion of $21,600 in principal of outstanding convertible promissory notes of the Company.
	Subsequent to September 30, 2013, shares of common stock totaling 5,688,155 were issued upon a $150 conversion of the Golden Gate debenture with the exercise of 43 warrants at $381.50 per share for $16,350. Golden Gate also advanced $50,000 for future exercise of warrants under the terms of the securities purchase agreements.
	New Debenture Issued
	On October 1, 2013 (the “Date of Issuance”), 3DIcon Corporation issued and sold to an accredited investor a Senior Convertible Note (the “Senior Note”) in the principal amount of $205,000 and a warrant to purchase 300,000 shares of the Company’s common stock at an exercise price equal to 110% of the closing bid price on September 30, 2013 (the “October 2013 Warrant”). The Senior Note included a $30,750 original issue discount. Accordingly, the Company received $174,250 gross proceeds from which the Company paid legal and documentation fees of $22,500 and placement agent fees of $15,682.
	The Senior Note matures on July 1, 2014 and does not carry interest. However, in the event the Senior Note is not paid on maturity, all past due amounts will accrue interest at 15% per annum. At any time subsequent to six months following the Date of Issuance, the Senior Note holder may elect to convert all or any portion of the outstanding principal amount of the Senior Note into shares of Common Stock at a conversion price equal to the lesser of 100% of the Volume Weighted Average Price (VWAP), as reported for the 5 trading days prior to the Date of Issuance or 80% of the average VWAP during the 5 days prior to the date the holder delivers a conversion notice to the Company.
	The estimated fair value of the warrants for common stock issued of $2,130 was determined using the Black-Scholes option pricing model. The expected dividend yield of zero is based on the average annual dividend yield as of the issue date. Expected volatility of 173.64% is based on the historical volatility of our stock. The risk-free interest rate of 1.39% is based on the U.S. Treasury Constant Maturity rate for five years as of the issue date. The expected life of five years of the warrant is based on historical exercise behavior and expected future experience.
	The October 2013 Warrant is exercisable at any time on or after March 31, 2014 and on or prior to the close of business on March 31, 2019. At the election of the October 2013 Warrant holder, the October 2013 Warrant may be exercised using a cashless exercise method.
	The Senior Note and October 2013 Warrant were offered and sold to an accredited investor in a private placement transaction made in reliance upon exemptions from registration pursuant to Section 4(2) under the Securities Act of 1933.
	Change in Management
	On November 1, 2013, Mark Willner resigned as Chief Executive Officer of 3DIcon Corporation in order to allow Victor F. Keen to take over in his place as the Company’s newly appointed Interim Chief Executive Officer.
	Mr. Willner’s resignation was not a result of any dispute with the Company. Furthermore, Mr. Willner will assume a strategic consulting role with the Company, focusing his efforts on the commercialization of and business development of the Company’s patented 3D display technology, CSpace®.
	Mr. Keen, formerly Co-Chairman of the Company’s Board of Directors, will remain a member of the Board while John M. O’Connor, also a former Co-Chairman, was newly elected as the sole Chairman of the Board. Mr. Keen has been a member of the Board since November 2007.

Uncertainties_and_Use_of_Estim1

Uncertainties and Use of Estimates (Policies)	9 Months Ended
	Sep. 30, 2013
Basis of Presentation	'
	Basis of Presentation
	The accompanying financial statements of 3DIcon Corporation (the “Company”) have been prepared without audit pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). Certain information and footnote disclosures normally included in the financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted pursuant to such rules and regulations. The Company believes that the disclosures made are adequate to make the information presented not misleading. These financial statements should be read in conjunction with the Company's year-end audited financial statements and related footnotes included in the previously filed 10-K. In the opinion of management, all adjustments, consisting only of normal recurring adjustments, necessary to present fairly the financial position of the Company as of September 30, 2013, and the statements of its operations for the three and nine months ended September 30, 2013 and 2012, and the period from inception (January 1, 2001) to September 30, 2013, and cash flows for the nine-month periods ended September 30, 2013 and 2012, and the period from inception (January 1, 2001) to September 30, 2013, have been included. The results of operations for interim periods may not be indicative of the results which may be realized for the full year.
Use of Estimates	'
	Use of Estimates
	The preparation of financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues, expenses and the disclosure of contingent assets and liabilities. Actual results could differ from the estimates and assumptions used.
Revenue Recognition	'
	Revenue Recognition
	Revenues from software license fees are accounted for in accordance with Accounting Standards Codification (“ASC”) 985-605, “Software Revenue Recognition”.  The Company recognizes revenue when (i) persuasive evidence of an arrangement exists; (ii) delivery has occurred or services have been rendered; (iii) the sales price is fixed or determinable; and (iv) collectability is reasonably assured.
	Grant revenue is recognized when earned.
Recent Accounting Pronouncements	'
	Recent Accounting Pronouncements
	Based on management's assessment no new accounting standards, if adopted, would have a material impact on the accompanying financial statements.
Uncertainties	'
	Uncertainties
	The accompanying financial statements have been prepared on a going concern basis.  The Company is in the development stage and has insufficient revenue and capital commitments to fund the development of its planned product and to pay operating expenses.
	The Company has realized a cumulative net loss of $19,673,704 for the period from inception (January 1, 2001) to September 30, 2013, and a net loss of $1,150,882 and $1,511,737 for the nine-months ended September 30, 2013 and 2012, respectively.
	The ability of the Company to continue as a going concern during the next year depends on the successful completion of the Company's capital raising efforts to fund the development of its planned products.  The financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.
	Management plans to fund the future operations of the Company with existing cash, grants and investor funding. Pursuant to the 4.75% Convertible Debenture due in December 2014, beginning in November 2007, Golden State is obligated to submit conversion notices in an amount such that Golden State receives 1% of the outstanding shares of the Company every calendar quarter for a period of one year or until the Debenture is converted in full.  In connection with each conversion, Golden State is expected to simultaneously exercise a percentage of warrants equal to the percentage of the principal being converted.  The warrants are exercisable at $381.50 per share.  The number of warrants exercisable is subject to certain beneficial ownership limitations contained in the 4.75% Convertible Debenture (“the Beneficial Ownership Limitations”).  The Beneficial Ownership Limitations prevent Golden State from converting on the 4.75% Convertible Debenture or exercising warrants if such conversion or exercise would cause Golden State’s holdings to exceed 9.99% of the Company’s issued and outstanding common stock.  Subject to the Beneficial Ownership Limitations and provided that Golden State is able to sell the shares under Rule 144, Golden State is required to convert $85.71 of the 4.75% Convertible Debenture and exercise 857 warrants per month.  Based upon our current stock price, our issued and outstanding shares as of September 30, 2013 and ignoring the impact of the Beneficial Ownership Limitations, the Company may receive up to $327,000 per month in funding from Golden State as a result of warrant exercises. During the nine-months ended September 30, 2013, the Company received $621,810 in funding under the terms of the 4.75% Convertible Debenture (see Note 4).
	Additionally, the Company is continuing to pursue financing through private offerings of debt or common stock.
	Registration Statement on Form S-1
	Pursuant to a Registration Statement on Form S-1 and the prospectus therein, filed on July 3, 2012, and amendment thereto, the Registration Statement was declared effective on February 13, 2013.

Debentures_and_Notes_Payable_T

Debentures and Notes Payable (Tables)	9 Months Ended
	Sep. 30, 2013
Debentures and Notes Payable [Abstract]	'
Debentures Payable	'
	Debentures payable consist of the following:
		September 30,		December 31,
		2013		2012
	Senior Convertible Debentures:
	10% Convertible debentures to Directors due June 2014	$	30,000	$	-
	10% Convertible debenture due November 2013		29,007		29,007
	4.75% Convertible debenture due December 2014		70,225		73,665
	5.0% Convertible notes due 2013 (net of $12,792 and $6,167 OID)		109,228		168,833
	15% Convertible bridge notes due 2014		158,987		403,000
	Settlement Agreement 3(a)(10)		129,758		-
	15% Convertible bridge note to Director due December 2013		60,000		60,000
	Total Debentures		587,205		734,505
	Less - Current Maturities		-516,980		-660,840
	Long-term Debentures	$	70,225	$	73,665

Common_Stock_and_PaidIn_Capita1

Common Stock and Paid-In Capital (Tables)	9 Months Ended
	Sep. 30, 2013
Common Stock, Including Additional Paid In Capital, Net Of Discount [Abstract]	'
Warrant and Option Activity	'
	The following summary reflects warrant and option activity for the nine-month period ended September 30, 2013:
		Attached		Golden State		Options
		Warrants		Warrants
	Outstanding December 31, 2012		221,122		21,045		3,045,989
	Granted/purchased		-		-		20,000,000
	Exercised		-		-983		-
	Cancelled		-		-		-
	Outstanding September 30, 2013		221,122		20,062		23,045,989

Office_Lease_Tables

Office Lease (Tables)	9 Months Ended
	Sep. 30, 2013
Office Lease [Abstract]	'
Minimum Future Lease Payments	'
	The minimum future lease payments to be paid annually under the three-year non-cancellable amended operating lease for office space are as follows:
	2013	$	6,000
	2014		23,000
	2015		13,000
	Total	$	42,000

Uncertainties_and_Use_of_Estim2

Uncertainties and Use of Estimates - Additional Information (Detail) (USD $)

3 Months Ended

9 Months Ended

12 Months Ended

153 Months Ended

9 Months Ended

Sep. 30, 2013

Sep. 30, 2012

Sep. 30, 2013

Sep. 30, 2012

Dec. 31, 2012

Dec. 31, 2011

Dec. 31, 2010

Dec. 31, 2009

Dec. 31, 2008

Dec. 31, 2007

Dec. 31, 2006

Dec. 31, 2005

Dec. 31, 2004

Dec. 31, 2003

Dec. 31, 2002

Dec. 31, 2001

Sep. 30, 2013

Sep. 30, 2013

Nov. 01, 2007

4.75% Debenture due 2014

4.75% Debenture due 2014

Golden State Debentures

Golden State Debentures

Unusual Risk or Uncertainty [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Net loss

($323,385)

($666,114)

($1,150,882)

($1,511,737)

($2,101,702)

($2,320,469)

($1,523,737)

($1,566,835)

($3,611,550)

($3,928,996)

($1,469,888)

($592,811)

($617,875)

($51,851)

($267,887)

($259,221)

($19,673,704)

'

'

Convertible Debenture, interest rate

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

4.75%

Receives outstanding shares upon submission of conversion notices

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

1.00%

Warrants exercise, price

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$381.50

'

Conversion or exercise cause Golden State's holdings to exceed of Company's issued and outstanding common stock

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

9.99%

'

Required amount of Convertible Debenture

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

85.71

'

Warrants exercised per month

300,000

'

300,000

'

'

'

'

'

'

'

'

'

'

'

'

'

300,000

857

'

Fund under terms of 4.75% Convertible Debenture

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

621,810

'

Funds from Golden State result warrant exercises

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$327,000

'

Sponsored_Research_Agreement_S1

Sponsored Research Agreement ("SRA") Common Stock Subject to Put Right and Call Right - Additional Information (Detail) (USD $)

3 Months Ended

9 Months Ended

153 Months Ended

9 Months Ended

1 Months Ended

9 Months Ended

1 Months Ended

0 Months Ended

1 Months Ended

Sep. 30, 2013

Sep. 30, 2012

Sep. 30, 2013

Sep. 30, 2012

Sep. 30, 2013

Sep. 30, 2013

Sep. 30, 2013

Dec. 01, 2012

Sep. 30, 2013

Sep. 30, 2013

Apr. 20, 2004

Apr. 15, 2005

Oct. 14, 2008

Dec. 01, 2010

Dec. 01, 2010

Put Option

Put Option

Call Option

Maximum

Maximum

Pilot Study to Investigate Digital Holography

Investigation of 3-Dimensional Display Technologies

3-Dimensional Display Development

3-Dimensional Display Development

3-Dimensional Display Development

Second Anniversary

Third Anniversary

Third Anniversary

Put Option

Put Option

Stock issued for cash

Second Anniversary

Third Anniversary

Research and Development Arrangement, Contract to Perform for Others [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Amount paid to University of Oklahoma

$90,035

$127,759

$280,796

$414,149

$4,958,471

'

'

'

'

'

$14,116

$528,843

'

$525,481

$40,481

Shares issued to University of Oklahoma for Sponsored Research Agreement

'

'

'

'

'

'

'

'

'

'

'

'

121,848

1,685,714

'

Market Value of shares issued to University of Oklahoma for Sponsored Research Agreement

'

'

'

'

'

'

'

'

'

'

'

'

290,000

'

'

Proceeds from equity

'

'

621,810

688,831

5,999,376

'

'

970,000

100,000

970,000

'

'

'

'

'

Redemption price of rights

'

'

'

'

'

$50,000

$485,000

'

'

'

'

'

'

'

'

OCAST_Grant_Additional_Informa

OCAST Grant - Additional Information (Detail) (USD $)	0 Months Ended	1 Months Ended	3 Months Ended		9 Months Ended		153 Months Ended
	Jul. 02, 2013	Nov. 19, 2008	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Dec. 31, 2009
Revenue Recognition, Multiple-deliverable Arrangements [Line Items]	'	'	'	'	'	'	'	'
Amount earned from grant	$300,000	$800,000,000	$0	$0	$0	$63,669	$281,492	'
Grant receivable	'	'	'	'	'	'	'	299,984
Direct costs incurred and for the use of the OU lab facilities	'	'	'	'	0	12,071	'	'
2009 | Maximum	'	'	'	'	'	'	'	'
Revenue Recognition, Multiple-deliverable Arrangements [Line Items]	'	'	'	'	'	'	'	'
Amount owed in direct costs	'	'	'	'	'	'	'	$149,940

Debentures_and_Notes_Payable_A

Debentures and Notes Payable - Additional Information (Detail) (USD $)

9 Months Ended

153 Months Ended

1 Months Ended

9 Months Ended

9 Months Ended

9 Months Ended

12 Months Ended

9 Months Ended

12 Months Ended

9 Months Ended

12 Months Ended

9 Months Ended

0 Months Ended

9 Months Ended

1 Months Ended

0 Months Ended

1 Months Ended

Sep. 30, 2013

Sep. 30, 2012

Sep. 30, 2013

Jul. 30, 2013

Jul. 30, 2013

Jul. 26, 2013

Sep. 30, 2013

Sep. 30, 2013

Jul. 01, 2014

Sep. 30, 2013

Sep. 30, 2013

Sep. 30, 2013

Sep. 30, 2013

Dec. 31, 2012

Nov. 03, 2006

Sep. 30, 2013

Dec. 31, 2012

Sep. 30, 2013

Dec. 31, 2012

Sep. 30, 2013

Dec. 31, 2012

Jun. 06, 2012

Aug. 01, 2012

Sep. 30, 2013

Jul. 03, 2012

Aug. 01, 2012

Apr. 30, 2013

Aug. 28, 2012

Aug. 28, 2012

Jan. 26, 2013

Sep. 11, 2012

Jan. 26, 2013

Dec. 20, 2012

Jun. 06, 2012

Jun. 24, 2013

Aug. 24, 2012

Dec. 21, 2012

Dec. 21, 2012

Dec. 21, 2012

Securities Purchase Agreement One

Securities Purchase Agreement Two

Settlement Agreement [Member]

Settlement Agreement [Member]

Second Keen Amendment

Subsequent Event

Subsequent Event

4.75% Debenture due 2014

4.75% Debenture due 2014

4.75% Debenture due 2014

4.75% Debenture due 2014

4.75% Debenture due 2014

4.75% Debenture due 2014

4.75% Debenture due 2014

4.75% Debenture due 2014

4.75% Debenture due 2014

5% Convertible Promissory Note

5% Convertible Promissory Note

5% Convertible Promissory Note

Convertible Note Two

Convertible Note Two

Convertible Note Two

Convertible Note Two

15% Convertible Bridge Notes

15% Convertible Bridge Notes

15% Convertible Bridge Notes

15% Convertible Bridge Notes

15% Convertible Bridge Notes

15% Convertible Bridge Notes

Newton O Connor Turner And Ketchum 10% Convertible Debenture

5% Convertible Promissory Note One

Victor Keen and Martin Keating 10% convertible debenture

GCA Strategic Investment Fund Limited

GCASIF Amendement

GCASIF Amendement

GCASIF Amendement

Convertible Debt

Settlement Agreement [Member]

If volume weighted average price is below $0.02

Golden State

Golden State

Golden State

Golden State

Golden State

Golden State

Golden State

Additional

George Widener

Victor Keen

Victor Keen

Widener Amendment

15% Convertible Bridge Notes

15% Convertible Bridge Notes

15% Convertible Bridge Notes

15% Convertible Bridge Notes

Applied to the exercise of warrants

Applied to the exercise of warrants

Unapplied advances

Unapplied advances

Maximum

Minimum

Debt Conversion [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Convertible debt, principal amount

'

'

'

'

'

'

$67,873

'

'

'

'

'

'

'

$100,000

'

'

'

'

'

'

$275,000

$140,000

'

'

'

'

$438,000

'

$60,000

'

$78,000

$29,007

'

$15,000

'

'

$325,000

$300,000

Convertible note, conversion price

'

'

'

'

'

'

$0.00

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$0.15

'

'

'

'

'

'

'

'

'

$0.03

'

$0.01

'

'

'

'

Convertible note, conversion description

'

'

'

'

'

'

'

'

'

'

'

'The conversion price for the 4.75% $100,000 convertible debenture is the lesser of (i) $4.00 (pre-split) or (ii) 80% of the average of the five lowest volume weighted average prices during the twenty (20) trading days prior to the conversion.

'

'

'

'

'

'

'

'

'

'

'convert all or a part of Note #2 into shares of the Company's common stock at a conversion rate equal to the lesser of (i) $0.15 or (ii) 70% of the lowest trade price during the twenty-five trading days prior to JMJs election to convert. If the Company repays Note #2 on or before ninety days from the date it was issued, the interest rate will be zero percent. If the Company does not repay Note #2 on or before ninety days from the date it was issued, a one-time interest charge of 5% shall be applied to the principal. The Company did not repay Note #2 within the ninety day period and $5,000 of interest has been accrued. The principal of Note #2 is due one year from the date of each of the principal amounts advanced.

'

'

'

'

'Upon maturity of the Bridge Notes, the holders of the Bridge Notes may elect to convert all or any portion of the outstanding principal amount of the Bridge Notes into (i) securities sold pursuant to an effective registration statement at the applicable offering price; or (ii) shares of common stock at a conversion price equal to the lesser of 100% of the Volume Weighted Average Price (VWAP), as reported for the 5 trading days prior to (a) the date of issuance of the Bridge Notes, (b) the maturity date of the Bridge Notes, or (c) the first closing date of the securities sold pursuant an effective registration statement. The GCA Bridge Note matured on or about November 22, 2012, on which date all past due amounts of the GCA Bridge Note began accruing interest at 15% per annum. Furthermore, on November 22, 2012, because the shares of the Companys common stock into which the GCA Bridge Note is convertible were not registered under an effective registration statement (the Registration Statement), GCASIF was entitled to liquidated damages equal to 2% of the outstanding principal for each 30 day period after the November 22, 2012 the Registration Statement is not declared effective (the Liquidated Damages).

'

'

'

'

'

'convert all or a part of Note #1 into shares of the Company's common stock at a conversion rate equal to the lesser of (i) $0.35 or (ii) 70% of the lowest trade price during the twenty-five trading days prior to JMJs election to convert. If the Company repays Note #1 on or before ninety days from the date it was issued, the interest rate will be zero percent. If the Company does not repay Note #1 on or before ninety days from the date it was issued, a one-time interest charge of 5% shall be applied to the principal sum. The Company did not repay Note #1 within the ninety-day period and $2,500 of interest has been accrued. The principal of Note #1 is due one year from the date of each of the principal amounts advanced.

'

'

'Pursuant to the GCASIF Amendment, GCASIF agreed to extend the maturity of the GCA Bridge Note from November 22, 2012 to March 21, 2013 and the Company agreed to (i) increase the principal amount of the GCA Bridge Note from $300,000 to $325,000; (ii) amend the conversion price of the GCA Bridge Note to the lesser of $0.04, or 100% of the Volume Weighted Average Price, as reported by Bloomberg, L.P., for the 5 trading days prior to the effective date of the Registration Statement; and (iii) grant additional registration rights to GCASIF from 5,172,414 shares to 8,000,000 shares of the Companys common stock into which the GCA Bridge Note may be convertible.

'

'

Advances on Debenture

'

'

'

'

'

'

'

'

'

'

'

'

100,000

100,000

'

'

'

'

'

80,000

'

'

75,000

'

'

'

'

'

'

'

'

'

'

75,000

'

'

'

'

'

Convertible debenture, amount converted

490,150

38,259

4,787,610

'

'

'

'

'

'

'

'

'

3,440

7,991

'

'

'

'

'

86,625

'

'

'

88,200

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Conversion of convertible debenture, shares issued

'

'

'

'

'

'

'

'

'

'

'

'

18,466,089

9,577,906

'

'

'

'

'

6,057,305

'

'

'

6,747,619

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Convertible debenture, conversion price per share

'

'

'

'

'

'

'

'

'

'

'

$0.02

'

'

'

'

'

'

'

$0.01

'

'

'

$0.00

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Debenture, prepay portion in percentage

'

'

'

'

'

'

'

'

'

'

'

135.00%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Warrants to purchase common stock, issued

300,000

'

300,000

'

'

'

'

'

'

'

983

'

'

'

28,571

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Warrants to purchase common stock, issued, price per share

'

'

'

'

'

'

'

'

'

'

381.5

'

'

381.5

381.5

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Exercise of warrants to purchase common stock

'

'

'

'

'

'

'

'

'

'

'

'

'

2,285

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Advance against future exercise of warrants

'

'

'

'

'

'

'

'

'

'

'

'

621,810

789,111

'

374,960

805,652

181,451

1

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Original issue discount

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

12,792

6,167

'

15,000

'

'

'

'

'

'

'

'

'

'

25,000

'

'

'

'

'

Original issue discount collected

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

22,645

'

'

8,000

'

'

'

'

'

'

'

'

'

'

6,000

'

'

'

'

'

Shares of common stock issuable under registration statement

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

4,750,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Registration statement filing period

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'120 days

'

'

'120 days

'

'

'

'

'

'

'

'

'

'

'

'

'

Liquidated damages

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

25,000

'

'

'

'

'

'

'

'

'

'

20,000

'

'

Debt Instrument, Unamortized Discount

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

73,000

'

'

'

'

'

'

'

'

'

'

'

Placement Agent Fees

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

27,675

'

'

'

'

'

'

'

'

'

'

'

Convertible Debenture, interest rate

'

'

'

'

'

'

'

10.00%

15.00%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

15.00%

'

15.00%

'

15.00%

'

'

10.00%

'

'

'

'

Debt instrument aggregate principal amount

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

78,000

'

60,000

'

'

'

'

300,000

300,000

'

'

Proceeds from notes payable

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

365,000

'

'

'

'

'

'

'

'

'

'

'

Conversion of convertible debentures into common stock

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

78,000

'

'

'

'

'

'

'

'

'

'

'

'

Conversion of convertible debentures into common stock, shares

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

2,025,974

'

'

'

'

'

'

'

'

'

'

'

'

Number of accredited investors

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

3

'

'

'

'

'

'

'

'

'

'

'

Legal Fees

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

25,000

'

'

'

'

'

'

'

'

'

'

'

Stock issued during period, shares, conversion of units

'

'

'

'

'

'

16,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

8,000,000

5,172,414

Debt instrument maturity date

'

'

'

'

'

'

'

15-May-13

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

30-Apr-13

'

'

'

'

'

'

'

'

'

Extended maturity date

'

'

'

30-Apr-13

15-May-13

'

'

31-Aug-13

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Accounts payable

'

'

'

'

'

$197,631

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Stock issued during period shares other

'

'

'

'

'

650,000

'

'

'

14,460,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Conversion rate to closing bid price

'

'

'

'

'

65.00%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Conversion closing bid price

'

'

'

'

'

$0.00

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Debentures_Payable_Detail

Debentures Payable (Detail) (USD $)	Sep. 30, 2013	Dec. 31, 2012
Debt Instrument [Line Items]	'	'
Senior Convertible Debentures	$587,205	$734,505
Less - Current Maturities	-516,980	-660,840
Long-term Debentures	70,225	73,665
10% convertible debentures from Directors due June 2014	'	'
Debt Instrument [Line Items]	'	'
Senior Convertible Debentures	30,000	0
10% Convertible debenture due November 2013	'	'
Debt Instrument [Line Items]	'	'
Senior Convertible Debentures	29,007	29,007
4.75% Convertible debenture due December 2014	'	'
Debt Instrument [Line Items]	'	'
Senior Convertible Debentures	70,225	73,665
5.0% Note due 2013	'	'
Debt Instrument [Line Items]	'	'
Senior Convertible Debentures	109,228	168,833
15% Convertible bridge notes due 2014	'	'
Debt Instrument [Line Items]	'	'
Senior Convertible Debentures	158,987	403,000
Settlement Agreement	'	'
Debt Instrument [Line Items]	'	'
Senior Convertible Debentures	129,758	0
15% Convertible bridge note to Director due December 2013	'	'
Debt Instrument [Line Items]	'	'
Senior Convertible Debentures	$60,000	$60,000

Common_Stock_and_PaidIn_Capita2

Common Stock and Paid-In Capital - Additional Information (Detail) (USD $)

0 Months Ended

1 Months Ended

9 Months Ended

12 Months Ended

9 Months Ended

0 Months Ended

1 Months Ended

9 Months Ended

0 Months Ended

3 Months Ended

0 Months Ended

1 Months Ended

9 Months Ended

0 Months Ended

3 Months Ended

Apr. 11, 2013

Apr. 27, 2012

Sep. 30, 2013

Sep. 30, 2013

Sep. 30, 2013

Sep. 30, 2013

Sep. 30, 2013

Sep. 30, 2013

Sep. 30, 2013

Dec. 31, 2012

Dec. 31, 2011

Dec. 31, 2010

Dec. 31, 2009

Dec. 31, 2008

Dec. 31, 2007

Dec. 31, 2006

Dec. 31, 2005

Dec. 31, 2004

Dec. 31, 2003

Dec. 31, 2002

Dec. 31, 2001

Sep. 30, 2013

Sep. 30, 2012

Sep. 30, 2013

Sep. 30, 2012

Mar. 13, 2012

Mar. 31, 2012

Sep. 30, 2013

Mar. 13, 2012

Dec. 31, 2012

Sep. 30, 2012

Jun. 30, 2012

Mar. 31, 2012

Jun. 30, 2012

Mar. 16, 2012

Mar. 31, 2012

Sep. 30, 2013

Mar. 16, 2012

Dec. 31, 2012

Sep. 30, 2012

Jun. 30, 2012

Mar. 31, 2012

Dec. 31, 2012

Sep. 30, 2012

Group Two

Group Two

Group Three

Group Three

Group Six

Group Six

Stock issued for services

Stock issued for services

Stock issued for services

Stock issued for services

Stock issued for services

Stock issued for services

Stock issued for services

Stock issued for services

Stock issued for services

Stock issued for services

Stock issued for services

Stock issued for services

Stock issued for services

Consulting Services

Consulting Services

Common Stock And Options Issued

Common Stock And Options Issued

Mark Willner

Mark Willner

Mark Willner

Mark Willner

Mark Willner

Mark Willner

Mark Willner

Mark Willner

Mark Willner

George Melnik

George Melnik

George Melnik

George Melnik

George Melnik

George Melnik

George Melnik

George Melnik

George Melnik

George Melnik

Expire on May 22, 2014

Expire on June 1, 2015

Expire on December 31,2014

Employee Stock Option

Employee Stock Option

Employee Stock Option

Employee Stock Option

Employee Stock Option

Scenario, Forecast

Employee Stock Option

Employee Stock Option

Employee Stock Option

Employee Stock Option

Employee Stock Option

Scenario, Forecast

Scenario, Forecast

Conversion of Stock [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Issued and outstanding common stock combined into one share of common stock due to Reverse Stock Split

'

35

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Warrants outstanding

'

'

125,098

'

96,024

'

20,062

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Warrants outstanding, exercise price

'

'

'

3.15

'

3.15

'

381.5

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Stock issued for consulting services, shares

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

12,505,475

1,848,691

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Stock issued for consulting services, value

'

'

'

'

'

'

'

'

$220,350

$246,100

$355,205

$232,886

$538,354

$313,800

$155,426

$206,537

$26,371

$76,489

$15,347

$129,448

$188,131

$220,350

$230,350

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Common stock issued to consultants for previous services provided

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

1,098,751

869,510

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Reduction in accounts payable liability

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

31,500

366,364

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Employment agreement, terms effective period

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'1 year

'

'

'

'

'

'

'

'

'1 year

'

'1 year

'

'

'

'

'

'

'

Annual base salary

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

180,000

'

'

'

'

'

'

'

'

144,000

'

'

'

'

'

'

'

'

'

Stock options granted, term

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'5 years

'

'

'

'

'

'

'

'

'5 years

'

'

'

'

'

'

'

'

'

Options granted

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

57,143

57,143

'

'

'

'

'

'

'

28,571.50

28,571

'

'

'

'

'

'

'

'

Stock option plan, exercise price

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$0.35

'

'

'

'

'

'

'

'

$0.35

'

'

'

'

'

'

'

'

'

Additional Stock option plan, shares granted

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

28,571.50

'

'

'

'

'

'

'

'

28,571.50

28,571.50

Estimated fair value of options

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

18,840

18,840

18,840

18,840

'

'

'

'

'

9,420

9,420

9,420

9,420

'

'

Expected dividend yield

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

0

'

'

'

'

'

'

'

'

0

'

'

'

'

'

'

Expected volatility

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

163.00%

'

'

'

'

'

'

'

'

163.00%

'

'

'

'

'

'

Risk-free interest

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

1.87%

'

'

'

'

'

'

'

'

1.87%

'

'

'

'

'

'

Expected life of option

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'5 years

'

'

'

'

'

'

'

'

'5 years

'

'

'

'

'

'

Employment agreement, termination period

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'60 days

'

'

'

'

'

'

'

'

'60 days

'

'

'

'

'

'

'

Share-based compensation arrangement by share-based payment award, options, grants in period, gross

10,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Maximum purchase of restricted common shares

10,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Maximum purchase of restricted common shares purchase price per share

$0.01

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Gross proceeds from options agreements

$100,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Warrant_and_Option_Activity_De

Warrant and Option Activity (Detail)	9 Months Ended
	Sep. 30, 2013
Attached Warrants	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'
Outstanding at beginning of period	221,122
Granted/purchased	0
Exercised	0
Cancelled	0
Outstanding at end of period	221,122
Golden State Warrants	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'
Outstanding at beginning of period	21,045
Granted/purchased	0
Exercised	-983
Cancelled	0
Outstanding at end of period	20,062
Options	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'
Outstanding at beginning of period	3,045,989
Granted/purchased	20,000,000
Exercised	0
Cancelled	0
Outstanding at end of period	23,045,989

Incentive_Stock_Plan_Additiona

Incentive Stock Plan - Additional Information (Detail)	9 Months Ended			9 Months Ended			6 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Jan. 31, 2011	Sep. 30, 2013	Sep. 30, 2012	Apr. 30, 2012	Jun. 30, 2013
	2011 Equity Incentive Stock Plan	2011 Equity Incentive Stock Plan	2011 Equity Incentive Stock Plan	2012 Equity Incentive Plan	2012 Equity Incentive Plan	2012 Equity Incentive Plan	2013 Equity Incentive Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'	'	'	'	'	'
Incentive stock plan, authorized	'	'	100,000,000	'	'	5,000,000	20,000,000
Incentive stock plan, issued	0	940,126	'	0	1,172,514	'	11,849,225
Incentive stock plan, shares available for issuance	44,673	'	'	1,072,536	'	'	8,150,755

Office_Lease_Additional_Inform

Office Lease - Additional Information (Detail)	9 Months Ended
	Sep. 30, 2013
Lease agreement commencement date	1-Jun-08
Lease expiration date	1-Jun-11
First Amendment	'
Lease agreement amendment date	'2011-03-08
Extended lease expiration date	'2012-05-31
Second Amendment	'
Lease agreement amendment date	'2012-07-24
Extended lease expiration date	'2015-07-31

Minimum_Future_Lease_Payments_

Minimum Future Lease Payments (Detail) (USD $)	Sep. 30, 2013
Future Minimum Payments Under Non-Cancelable Operating Leases With Initial Terms Of One-Year Or More [Line Items]	'
2013	$6,000
2014	23,000
2015	13,000
Total	$42,000

Related_Party_Transaction_Addi

Related Party Transaction - Additional Information (Detail) (Newton, O'Connor, Turner & Ketchum, a professional corporation ("NOTK"), USD $)	9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012
Newton, O'Connor, Turner & Ketchum, a professional corporation ("NOTK")	'	'
Related Party Transaction [Line Items]	'	'
Legal fees incurred to Newton	$18,595	$17,068

Subsequent_Events_Additional_I

Subsequent Events - Additional Information (Detail) (USD $)

9 Months Ended

12 Months Ended

153 Months Ended

9 Months Ended

1 Months Ended

9 Months Ended

Sep. 30, 2013

Sep. 30, 2012

Dec. 31, 2010

Dec. 31, 2009

Dec. 31, 2008

Dec. 31, 2005

Dec. 31, 2004

Sep. 30, 2013

Sep. 30, 2013

Sep. 30, 2013

Jul. 26, 2013

Sep. 30, 2013

Sep. 30, 2013

Jul. 01, 2014

Sep. 30, 2013

Sep. 30, 2013

Sep. 30, 2013

Sep. 30, 2013

Senior Convertible Note

Warrant

Settlement Agreement

Second Keen Amendment

4.75% Debenture due 2014

Subsequent Event

Subsequent Event

Subsequent Event

Subsequent Event

Subsequent Event

Golden Gate Debenture

Settlement Agreement

Consulting Services

Convertible Promissory Notes

Debt Instrument [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Number of warrants exercised

'

'

'

'

'

'

'

'

'

'

'

'

'

'

43

'

'

'

Warrants exercise price per share

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$381.50

'

'

'

Advance payment for future exercise of warrants

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$50,000

'

'

'

Expense recognized for common stock shares issued for services

220,350

230,350

'

'

'

'

'

2,704,445

'

'

'

'

'

'

'

'

30,000

'

Debt instrument face amount

'

'

'

'

'

'

'

'

205,000

'

'

'

'

'

'

'

'

'

Debt conversion converted instrument amount

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

6,265

'

21,600

Convertible Debenture, interest rate

'

'

'

'

'

'

'

'

'

'

'

10.00%

'

15.00%

'

'

'

'

Stock issued during period shares other

'

'

'

'

'

'

'

'

'

'

650,000

'

'

'

'

14,460,000

2,485,542

14,400,000

Stock Issued During Period Value Stock Warrants Exercised

'

'

518,000

382,590

362,694

174,000

61,000

'

'

'

'

'

'

'

16,350

'

'

'

Class of warrant or right number of securities called by warrants or rights

300,000

'

'

'

'

'

'

300,000

'

'

'

'

983

'

'

'

'

'

Debt instrument unamortized discount

'

'

'

'

'

'

'

'

30,750

'

'

'

'

'

'

'

'

'

Proceeds from notes payable

'

'

'

'

'

'

'

'

174,250

'

'

'

'

'

'

'

'

'

Legal fees

'

'

'

'

'

'

'

'

22,500

'

'

'

'

'

'

'

'

'

Placement agent fees

'

'

'

'

'

'

'

'

15,682

'

'

'

'

'

'

'

'

'

Estimated Fair Value Of Warrants

'

'

'

'

'

'

'

'

'

$2,130

'

'

'

'

'

'

'

'

Fair value assumptions expected volatility rate

'

'

'

'

'

'

'

'

'

173.64%

'

'

'

'

'

'

'

'

Fair value assumptions, risk free interest rate

'

'

'

'

'

'

'

'

'

1.39%

'

'

'

'

'

'

'

'

Fair value assumptions expected dividend rate

'

'

'

'

'

'

'

'

'

0.00%

'

'

'

'

'

'

'

'

Convertible note, conversion price

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$150

'

'

'

Stock issued during period, shares, conversion of units

'

'

'

'

'

'

'

'

'

'

'

'

'

'

5,688,155

'

'

'

Debt instrument convertible terms of conversion feature

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'the Senior Note holder may elect to convert all or any portion of the outstanding principal amount of the Senior Note into shares of Common Stock at a conversion price equal to the lesser of 100% of the Volume Weighted Average Price (VWAP), as reported for the 5 trading days prior to the Date of Issuance or 80% of the average VWAP during the 5 days prior to the date the holder delivers a conversion notice to the Company

'

'

'

Fair value assumptions expected term

'

'

'

'

'

'

'

'

'

'5 years

'

'

'

'

'

'

'

'

Class of warrant or right exercise price description

'110% of the closing bid price

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'